GENETICS AND CELL PHYSIOLOGY OF MURINE TISSUE FACTOR
鼠组织因子的遗传学和细胞生理学
基本信息
- 批准号:3196547
- 负责人:
- 金额:$ 19.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-12-01 至 1994-07-31
- 项目状态:已结题
- 来源:
- 关键词:antibody formation blood coagulation disorders clone cells complementary DNA cycloheximide epidermal growth factor fibroblast growth factor hemostasis laboratory mouse messenger RNA nucleic acid sequence peptides physiology polymerase chain reaction protein biosynthesis protein structure function transfection
项目摘要
Metastatic cancer and certain other proliferative diseases are frequently
associated with aberrations of blood coagulation. The molecular basis for
this is poorly understood but may involve a linkage between growth
regulatory mechanisms and those that regulate hemostasis. This research
seeks to further define such a link by establishing the functional
significance of a newly identified mouse protein related to human tissue
factor, a cell surface receptor responsible for initiating the protease
cascade leading to blood coagulation. The amino acid sequence of this
protein was deduced from the nucleotide sequence of cDNA clones originally
selected on the basis of inducible expression in peptide growth
factor-stimulated mouse fibroblasts. An analysis of this sequence indicates
that this clone represents either murine tissue factor or the first known
example of an homologous protein. The major objective of this research
proposal is to determine whether this protein is functionally equivalent
to tissue factor, and if so, to determine whether the two are isogenic or
the products of related genes. In addition, this research will explore the
possibility that this protein is multifunctional with growth-associated
properties unrelated to hemostasis. These objectives will be accomplished,
in part, using a combination of molecular and immunological approaches to
establish the relationship between expression of the mouse protein and
phenotypic alterations in procoagulant activity and other specific
responses to peptide growth factors.
转移性癌症和某些其他增生性疾病经常是
与血液凝血的畸变有关。分子基础
这是很少的理解,但可能涉及增长之间的联系
调节机制和调节止血的机制。这项研究
试图通过建立功能来进一步定义这种链接
与人组织有关的新鉴定的小鼠蛋白的意义
因子,一种负责启动蛋白酶的细胞表面受体
级联导致血液凝血。此的氨基酸序列
从最初的cDNA克隆的核苷酸序列推导蛋白质
根据肽生长的诱导表达选择
因子刺激的小鼠成纤维细胞。对此序列的分析表明
该克隆代表鼠组织因子或第一个已知的因子
同源蛋白的示例。这项研究的主要目标
建议是确定该蛋白在功能上是否等效
到组织因子,如果是的,则确定两者是同源的还是
相关基因的产物。此外,这项研究将探索
该蛋白与生长相关的可能性多功能
与止血无关的特性。这些目标将实现,
部分结合了分子和免疫学方法
建立小鼠蛋白表达与
促凝活性和其他特定的表型改变
对肽生长因子的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J. GETZ其他文献
MICHAEL J. GETZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J. GETZ', 18)}}的其他基金
CAF, A COACTIVATOR OF FOS, AND BREAST CANCER
CAF、FOS 的协同激活剂和乳腺癌
- 批准号:
2447341 - 财政年份:1997
- 资助金额:
$ 19.06万 - 项目类别:
CAF, A COACTIVATOR OF FOS, AND BREAST CANCER
CAF、FOS 的协同激活剂和乳腺癌
- 批准号:
2837758 - 财政年份:1997
- 资助金额:
$ 19.06万 - 项目类别:
GENETICS AND CELL PHYSIOLOGY OF MURINE TISSUE FACTOR
鼠组织因子的遗传学和细胞生理学
- 批准号:
3196546 - 财政年份:1990
- 资助金额:
$ 19.06万 - 项目类别:
GENETICS AND CELL PHYSIOLOGY OF MURINE TISSUE FACTOR
鼠组织因子的遗传学和细胞生理学
- 批准号:
3196544 - 财政年份:1990
- 资助金额:
$ 19.06万 - 项目类别:
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCER
癌症多学科基础研究培训
- 批准号:
3533221 - 财政年份:1988
- 资助金额:
$ 19.06万 - 项目类别:
相似海外基金
Engineered CARs Targeting FVIII-specific T and B Cells
针对 FVIII 特异性 T 和 B 细胞的工程化 CAR
- 批准号:
9258469 - 财政年份:2016
- 资助金额:
$ 19.06万 - 项目类别:
Vascular networks genetically engineered for protein drug delivery
用于蛋白质药物输送的基因工程血管网络
- 批准号:
10457445 - 财政年份:2015
- 资助金额:
$ 19.06万 - 项目类别:
Vascular networks genetically engineered for protein drug delivery
用于蛋白质药物输送的基因工程血管网络
- 批准号:
10297294 - 财政年份:2015
- 资助金额:
$ 19.06万 - 项目类别:
Induction of Tolerance to FVIII in Hemophilia
血友病中 FVIII 耐受的诱导
- 批准号:
9260046 - 财政年份:2015
- 资助金额:
$ 19.06万 - 项目类别: